coronary atherosclerotic heart disease
Conditions
Interventions
intervention group :Clinical pharmacists and community pharmacists provide continuous pharmaceutical services to patients from admission to discharge for 1 month
usual group:Routine service by pharmacists
Sponsors
Aerospace Center Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1 Admission diagnosis of "coronary atherosclerotic heart disease". 2 At least one drug-related problems (DRPs) at the time of admission. 3 18~80 years old. 4 Sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1 Patients combined with severe hepatic and renal function abnormalities. 2 Patients with malignant tumors. 3 People with consciousness, mental and communication disorders. 4 People who failed to sign the informed content.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of drug-related problems (based on Pharmaceutical Care Network Europe standards); | — |
Secondary
| Measure | Time frame |
|---|---|
| Willingness to pay for pharmaceutical services;Control rate of low-density lipoprotein cholesterol (LDL-C);Proportion of good medication adherence (MARS-5 medication adherence scale, with a score of >= 23 indicating a good level of medication adherence);Service time;Control rate of blood pressure (BP);Control rate of glycated hemoglobin (HbA1c);Satisfaction score; | — |
Countries
China
Contacts
Public ContactLiu Hua
Aerospace Center Hospital
Outcome results
None listed